PHARMA MIX M 300

ACTIVE HALF-LIFE
5-6 days
CLASSIFICATION
Anabolic Steroid
DOSAGE
Men: 300-900 mg/week
ACNE
Yes
WATER RETENTION
Low
HBR
No
HEPATOTOXICITY
Low
AROMATIZATION
No
CARRIER OIL
Grapeseed Oil
MANUFACTURER
Pharmacom Labs - US
LAB TEST
See Document
WAREHOUSE
USA Warehouse 4
SUBSTANCE
Drostanolone Enanthate, Drostanolone Propionate

Introducing PHARMAMIX M 300?an innovative blend of two drostanolone esters: propionate and enanthate. This powerful formulation is designed for those on extended cycles, aiming to achieve high-quality lean muscle mass with a dense, aesthetic appearance. It effectively minimizes excess subcutaneous water retention, a common concern with long esters. For optimal results, PHARMAMIX M 300 works synergistically with testosterone and trenbolone combinations (such as PHARMA SUST 300, 500; PHARMA 3-TREN) as well as long-acting testosterone and trenbolone esters (like PHARMA TEST E300, E500, C250; PHARMA TREN E200, H100). Experience the success of our latest product, PHARMA MIX 6, which has quickly gained popularity, much like PHARMA MIX 2.

Drostanolone, first developed in 1959 by Syntex and launched in 1970 under the brand name Masteron, is a potent injectable anabolic steroid derived from dihydrotestosterone (DHT). Noted for its remarkable anabolic effects and anti-estrogenic properties, drostanolone was FDA-approved for treating inoperable breast cancer in postmenopausal women and is recognized for its therapeutic benefits worldwide.

Masteron's biological activity closely mirrors that of DHT, making it especially effective during cutting cycles, particularly for those already lean. It is non-aromatizing, resulting in no water retention, and carries a moderate diuretic effect similar to stanozolol, enhancing muscle density and definition. This compound is known for promoting optimal muscle condition, largely due to its lipolytic properties, which can facilitate a reduction in body fat by approximately 5-7%. It's an ideal choice for track and field athletes and bodybuilders striving to maintain their weight class.

While Masteron's bulking effects may be modest compared to other anabolic steroids, it can produce gains similar to those from Primobolan at higher doses. However, many anabolic alternatives are better suited for mass gain. Importantly, Masteron does not convert to estrogen and possesses anti-estrogenic qualities, making it a valuable asset in breast cancer treatment.

In summary, drostanolone offers effects akin to stanozolol but without the associated side effects often seen with Winstrol. It does not contribute to tendon brittleness, does not deplete joint fluid, and presents fewer adverse impacts on blood cholesterol levels compared to stanozolol. Thus, for those looking for a safer, more effective option during a cutting cycle, drostanolone stands out as a superior choice.